PatientSpotlight, by PanaceaIntelPatientSpotlight

Topic · Oncology

Delivery

Coverage of how therapies are delivered to patients - IV infusion, subcutaneous formulations, oral and inhaled regimens, and the operational shape of routine treatment. 2 pieces on delivery in Oncology, newest first within each collection.

← All topics
FilterAll (37)Oncology (2)Rare Disease (6)Neurology (7)Cardiometabolic (6)Respiratory (2)Women's Health (3)Mental Health (2)Ophthalmology (9)

Signals

2
SignalApr 30, 2026

Tumor-infiltrating lymphocyte therapy expands past melanoma

TIL therapy approval in metastatic melanoma is opening pathways into cervical and other solid tumour indications.

TreatmentPipelineDeliveryDrug development
SignalApr 26, 2026FDA · peer-reviewed

Bispecific T-cell engager uptake in lymphoma is constrained by cytokine-release-syndrome management capacity

Bispecific T-cell engagers in B-cell lymphoma are demonstrating strong response rates in late-line settings, but commercial uptake is limited by the cytokine-release-syndrome management infrastructure required for safe administration. The constraint is more binding than the clinical evidence base suggests.

PipelineDeliveryTreatment